PCI complications: restenosis

Revision as of 20:33, 18 January 2013 by Shankar Kumar (talk | contribs)
Jump to navigation Jump to search

Percutaneous coronary intervention Microchapters

Home

Patient Information

Overview

Risk Stratification and Benefits of PCI

Preparation of the Patient for PCI

Equipment Used During PCI

Pharmacotherapy to Support PCI

Vascular Closure Devices

Recommendations for Perioperative Management–Timing of Elective Noncardiac Surgery in Patients Treated With PCI and DAPT

Post-PCI Management

Risk Reduction After PCI

Post-PCI follow up

Hybrid coronary revascularization

PCI approaches

PCI Complications

Factors Associated with Complications
Vessel Perforation
Dissection
Distal Embolization
No-reflow
Coronary Vasospasm
Abrupt Closure
Access Site Complications
Peri-procedure Bleeding
Restenosis
Renal Failure
Thrombocytopenia
Late Acquired Stent Malapposition
Loss of Side Branch
Multiple Complications

PCI in Specific Patients

Cardiogenic Shock
Left Main Coronary Artery Disease
Refractory Ventricular Arrhythmia
Severely Depressed Ventricular Function
Sole Remaining Conduit
Unprotected Left Main Patient
Adjuncts for High Risk PCI

PCI in Specific Lesion Types

Classification of the Lesion
The Calcified Lesion
The Ostial Lesion
The Angulated or Tortuous Lesion
The Bifurcation Lesion
The Long Lesion
The Bridge Lesion
Vasospasm
The Chronic Total Occlusion
The Left Internal Mammary Artery
Multivessel Disease
Distal Anastomotic Lesions
Left Main Intervention
The Thrombotic Lesion

PCI complications: restenosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of PCI complications: restenosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on PCI complications: restenosis

CDC on PCI complications: restenosis

PCI complications: restenosis in the news

Blogs on PCI complications: restenosis

Directions to Hospitals Treating Percutaneous coronary intervention

Risk calculators and risk factors for PCI complications: restenosis

Editors-In-Chief: Alexandra Almonacid M.D.; Jeffrey J. Popma M.D.

Restenosis

In the setting of in-stent restenosis (ISR) after bare metal stent (BMS) implantation, the risk of recurrence can be predicted by the pattern of restenosis.

Classification

Table 1. Mehran Classification System (1)

  • Pattern I: Focal (≤ 10 mm in length) lesions
    • Ia : Restenosis within the stent
    • Ib : Restenosis at the edge of the stent
    • Ic : Restenosis at the articulation or gap
    • Id : Restenosis multifocal
  • Pattern II: ISR >10 mm within the stent
  • Pattern III: Includes ISR > 10 mm extending outside the stent
  • Pattern IV: ISR totally occluded

Implications

The need for recurrent target lesion revascularization (TLR) increased with increasing ISR class, increasing from 19%, 35%, 50%, to 83% in classes I to IV, respectively (P <0.001) (1).

Restenosis after drug eluting stent implantation is generally more focal than following bare metal stent placement (3, 4), and, with the sirolimus eluting stent, more is commonly at the margin of the stent due to balloon injury that is not covered with stent (3, 5).

References

Template:WH Template:WS

  1. ref1 pmid=10545431 This is free space so that you can describe the reference if you want
  2. ref2 pmid=16504631 This is free space so that you can describe the reference if you want
  3. ref3 pmid=15596568 This is free space so that you can describe the reference if you want
  4. ref4 pmid=12719283 This is free space so that you can describe the reference if you want
  5. ref5 pmid=12860901 This is free space so that you can describe the reference if you want

Template:WikiDoc Sources